Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Belitsky

Showing results (171-180 of 289) with videos related to

Pageof 29
Sort By:
Transplantation Proceedings|February 1, 1987
Significance of delayed function in cyclosporine-treated cadaver kidney transplantsP Belitsky, A S MacDonald, J Gajewski, et al.
Transplantation Proceedings|November 21, 1997
Use of rabbit anti-thymocyte globulin for induction immunosuppression in high-risk kidney transplant recipientsP Belitsky, A S MacDonald, J Lawen, et al.
Transplantation Proceedings|November 13, 2003
Basiliximab widens the therapeutic window for AUC-monitored neoral therapy early after kidney transplantationF Balbontin, B Kiberd, D Singh, et al.
Urology|January 18, 2006
Early recurrence of primary focal segmental glomerulosclerosis in an older cadaveric renal allograft recipient resistant to plasmapheresisDharm Singh, Ken West, Khaled Kamal, et al.
Transplantation Proceedings|June 17, 2000
A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levelsK Mahalati, P Belitsky, K West, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 1, 1983
Carcinoma of the penis: an 11-year reviewR W Norman, O H Millard, F G Mack, et al.
IARC Scientific Publications|January 1, 1991
Carcinogenic substances in Soviet tobacco productsD G Zaridze, R D Safaev, G A Belitsky, et al.
Clinical Therapeutics|July 16, 2003
A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001Stephen Pollard, Björn Nashan, Atholl Johnston, et al.
Transplantation Proceedings|April 1, 1989
ABO-incompatible living related donor kidney transplantation: report of two casesA S MacDonald, P Belitsky, H Bitter-Seurmann, et al.
Transplantation Proceedings|April 1, 1989
Living related donor kidney grafts in the cyclosporine eraA S MacDonald, P Belitsky, H Bitter-Suermann, et al.
Pageof 29

Showing results (171-180 of 289) with videos related to

Sort By:
Pageof 29
Transplantation Proceedings|February 1, 1987
Significance of delayed function in cyclosporine-treated cadaver kidney transplantsP Belitsky, A S MacDonald, J Gajewski, et al.
Transplantation Proceedings|November 21, 1997
Use of rabbit anti-thymocyte globulin for induction immunosuppression in high-risk kidney transplant recipientsP Belitsky, A S MacDonald, J Lawen, et al.
Transplantation Proceedings|November 13, 2003
Basiliximab widens the therapeutic window for AUC-monitored neoral therapy early after kidney transplantationF Balbontin, B Kiberd, D Singh, et al.
Urology|January 18, 2006
Early recurrence of primary focal segmental glomerulosclerosis in an older cadaveric renal allograft recipient resistant to plasmapheresisDharm Singh, Ken West, Khaled Kamal, et al.
Transplantation Proceedings|June 17, 2000
A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levelsK Mahalati, P Belitsky, K West, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|September 1, 1983
Carcinoma of the penis: an 11-year reviewR W Norman, O H Millard, F G Mack, et al.
IARC Scientific Publications|January 1, 1991
Carcinogenic substances in Soviet tobacco productsD G Zaridze, R D Safaev, G A Belitsky, et al.
Clinical Therapeutics|July 16, 2003
A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001Stephen Pollard, Björn Nashan, Atholl Johnston, et al.
Transplantation Proceedings|April 1, 1989
ABO-incompatible living related donor kidney transplantation: report of two casesA S MacDonald, P Belitsky, H Bitter-Seurmann, et al.
Transplantation Proceedings|April 1, 1989
Living related donor kidney grafts in the cyclosporine eraA S MacDonald, P Belitsky, H Bitter-Suermann, et al.
Pageof 29